Six More Biosimilars Lined Up For Approval By EMA
Three Ustekinumab Biosimilars And Three Other mAbs Receive CHMP Endorsement
Executive Summary
Six biosimilars have received positive opinions from the European Medicines Agency’s Committee for Medicinal Products for Human Use at its July meeting.